TransMedics Group, Inc. is a medical technology company that is revolutionizing organ transplant therapy for patients suffering from end-stage organ failure. This commercial-stage company offers its proprietary Organ Care System (OCS) that aims to replicate near-physiologic conditions for donor organs outside of the human body. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes the company's customized technology. The OCS system has various tools, such as the OCS LUNG, the OCS Heart, and the OCS Liver, which cater to the preservation and improvement of the quality of donor organs. Their OCS Lung is for the preservation of standard criteria donor lungs to prepare for double-lung transplantation, while the OCS Heart is designed for the preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage. TransMedics' OCS Liver, on the other hand, is for the preservation of donor livers. Founded in 1998, the company's headquarters is based in Andover, Massachusetts.
TransMedics Group's ticker is TMDX
The company's shares trade on the NASDAQ stock exchange
They are based in Andover, Massachusetts
There are 51-200 employees working at TransMedics Group
It is transmedics.com
TransMedics Group is in the Healthcare sector